Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

UGT1A1*28

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

UGT1A1*28	Colorectal Cancer	UGT1A1*28	Colorectal Cancer	capecitabine + irinotecan Sensitive: B - Late Trials capecitabine + irinotecan Sensitive : B	capecitabine + irinotecan Sensitive: B - Late Trials capecitabine + irinotecan Sensitive : B
UGT1A1*28	Colorectal Cancer	UGT1A1*28	Colorectal Cancer	bevacizumab Sensitive: C2 – Inclusion Criteria bevacizumab Sensitive : C2	bevacizumab Sensitive: C2 – Inclusion Criteria bevacizumab Sensitive : C2
UGT1A1*28	Non Small Cell Lung Cancer	UGT1A1*28	Non Small Cell Lung Cancer	irinotecan Sensitive: C3 – Early Trials irinotecan Sensitive : C3	irinotecan Sensitive: C3 – Early Trials irinotecan Sensitive : C3
UGT1A1*28	Colorectal Cancer	UGT1A1*28	Colorectal Cancer	FOLFIRI Sensitive: C3 – Early Trials FOLFIRI Sensitive : C3	FOLFIRI Sensitive: C3 – Early Trials FOLFIRI Sensitive : C3